Repurposing FDA‐approved drugs to target malaria through inhibition of dihydrofolate reductase in the folate biosynthesis pathway: A prospective approach.
- Resource Type
- Article
- Source
- Journal of Cellular Biochemistry; Mar2024, Vol. 125 Issue 3, p1-14, 14p
- Subject
- Language
- ISSN
- 07302312